Contract Pharma

APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News

Lonza Expands API Development, Mfg. Facility in China

20M CHF investment will include three 1,000L GMP trains and new development and GMP labs with HPAPI capabilities.

06.28.21

Breaking News | Excipients | Facilities | Industry News

Crystec Launches New R&D Center in China

New site in Haimen, Jiangsu province has been established following an invitation to participate in the Yangtze Delta Advanced Drug Development platform.

Tim Wright, Editor, Contract Pharma 04.05.21

WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China

Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.

Tim Wright, Editor, Contract Pharma 03.17.21

Breaking News | cGMP Manufacture | Drug Development | Industry News

Vetter Establishes Office in China

Additional office in Asia Pacific region to promote development of new business in China.

Kristin Brooks 03.08.21

Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China

Companies join forces in cell therapy applications and commercial-scale manufacturing.

Tim Wright, Editor, Contract Pharma 02.08.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China

Sign an agreement to provide 100 million doses of their BNT162 mRNA-based vaccine candidate in 2021.

Contract Pharma Staff 12.18.20

Excipients

Bye-Bye China?

Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.

Michele Jermini and Enrico Polastro 11.17.20

Bio News | Breaking News | Facilities | Industry News

Crown Biosciences Opens Facility in China

Full operational capacity is expected in early 2021.

Contract Pharma Staff 11.03.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Samsung Biologics Expands in China

Partners with Chinese biotech GeneQuantum Healthcare on ADC development.

Contract Pharma Staff 11.03.20

Importing Clinical Supplies into China

Water Cooler Chat

Breaking News | Clinical Trials | Industry News

Octapharma Supports New COVID-19 Trial

Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failure

Contract Pharma Staff 04.16.20

Bio News | Breaking News | Industry News | Inspections

WuXi Biologics Passes EMA GMP Inspection

Suzhou site clears regulatory hurdle with not critical findings

Contract Pharma Staff 04.15.20

Breaking News | Facilities | Industry News

PharmaBlock Opens New Facility in Zhejiang, China

New chemistry and engineering technology center highlights the application of micropacked bed technology in continuous manufacturing

Contract Pharma Staff 04.15.20

Biologics, Proteins, Vaccines | Drug Development | Information Technology

Speeding Vaccine Development with Advanced Analytics

Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process

Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 04.15.20

Drug Development | R&D

COVID-19 and the Importance of Combating Antimicrobial Resistance

Dr. Frank of Working to Fight AMR discusses the global COVID-19 pandemic and the critical need to address the public health crisis of Antimicrobial Resistance

Online Exclusives Kristin Brooks, Contract Pharma 04.13.20

Breaking News | Facilities | Industry News

ISPE Award Honors New Pfizer Facility

Engineered and designed by CRB, Andover Clinical Manufacturing Facility focuses on integration and flexibility to speed patient therapies

Contract Pharma Staff 04.13.20

Bio News | Breaking News | Facilities | Industry News

Seneca Completes Stem Cell Manufacturing Facility

Will be used to manufacture the company's lead stem cell therapy for clinical trials within China

Contract Pharma Staff 04.13.20

Breaking News | Clinical Trials | Industry News | Supply Chain

Marken Expands Clinical Trial Services

Critical need for patients to receive treatment at home spurs sponsor requests

Contract Pharma Staff 04.13.20

Collaborations & Alliances | Drug Development

Regeneron, Zai Lab Enter Strategic REGN1979 Alliance

Regeneron will receive $30 million upfront and is eligible to receive up to $160 million in additional regulatory and sales milestones.

Contract Pharma Staff 04.08.20

Bio News | Breaking News | Industry News | Laboratory Testing

BGI Unveils Inflatable Biosafety Lab for COVID-19 Testing

Huo-Yan Air Lab modular air dome structure can be transported by air as standard freight

Contract Pharma Staff 04.06.20

Clinical Trials

COVID-19: Keeping Clinical Trials Moving

How DTP and virtual services keep clinical trials moving during pandemic and beyond

Ariette van Strien, President, Marken 04.06.20

Breaking News | Promotions & Moves

CMAB Biopharma Appoints Head of Quality

Ye Shi will be responsible for the overall management of the quality system within CMAB.

Contract Pharma Staff 04.06.20

Breaking News | Industry News

FDA COVID-19 Update

Efforts underway to facilitate access to convalescent plasma for COVID-19 patients

Contract Pharma Staff 04.06.20

Breaking News | CRO News | Industry News

Frontage Laboratories Acquires Biotranix

Expands drug metabolism and pharmacokinetic services

Contract Pharma Staff 04.03.20

Breaking News | Industry News | Promotions & Moves

CMAB Bolsters Executive Team

Names Ye Shi as head of quality

Contract Pharma Staff 04.03.20

APIs

SOPs to Spur Growth in API Manufacturing

CMOs see outsourcing prospects improve

S. Harachand, Contributing Editor 04.01.20

The Supply Chain House of Cards

The COVID-19 pandemic exposes pressures on extended global supply chains

Emil W. Ciurczak, DoraMaxx Consulting 04.01.20

COVID-19 & Fear of the Unkown

We should be just as concerned with curbing the spread of fear, as we are the coronavirus

Tim Wright, Editor, Contract Pharma 04.01.20

Coronavirus SARS-CoV-2: Architecture of a Pandemic

Deconstructing the epidemiology of a global panic.

Ben Locwin, Contributing Editor 04.01.20

Breaking News | Collaborations & Alliances | Industry News

Citius, Novellus Ink COVID-19 Pact

Citius to license novel stem-cell therapy for acute respiratory distress syndrome (ARDS) associated with COVID-19

04.01.20

Breaking News | Collaborations & Alliances | Drug Development

Innovent, Alector Enter Oncology Alliance

To develop and commercialize an anti-SIRP-alpha antibody (Alector's AL008) for the treatment of oncology indications in China.

03.31.20

cGMP Manufacture | Drug Development | Logistics | Supply Chain

COVID-19: Business Update

Thermo Fisher Scientific provides perspective on the COVID-19 pandemic and how the company is working to help minimize disruptions

Online Exclusives Kristin Brooks, Contract Pharma 03.30.20

Bio News | Breaking News | Industry News

BioDuro to Develop COVID-19 Nanobody Therapeutic

Specialized COVID-19 team and technology assembled to accelerate discovery of new biologic

03.27.20

Supply Chain

Best Practices for Supply Chain Disruption

Top 3 “Best Practice” methods for planning your product label orders during supply chain disruption

Rob Freeman, Director of Business Development and Marketing, Label Solutions Inc. 03.27.20

Bio News | Breaking News | cGMP Manufacture | Scale-up/Technology Transfer

Sartorius Supports Coronavirus Vax Candidate

BIOSTAT STR single-use bioreactor system used for the upstream preparation of the recombinant vaccine

03.25.20

Breaking News | Excipients | Industry News

Wacker Receives Excipient Certification

Eddyville, IA site awarded EXCiPACT GMP certificate

03.24.20

Breaking News | Facilities | Industry News

CMAB Biopharma Resumes Full-Scale Operation

Suzhou, China site up and running following the coronavirus outbreak

03.24.20

Breaking News | CRO News | Facilities | Industry News

ChemPartner Expands China Ops

Introduces new state-of-the-art global operation center in Shanghai

03.20.20

Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Bright Path Labs Accepted into FDA's Emerging Technology Program

Scalable continuous manufacturing technology paves way for rapid, low-cost domestic API production

03.19.20

Breaking News | Clinical Trials | Drug Development | Industry News | Trials & Filings

Roche Trial to Assess Actemra/RoActemra in COVID-19 Pneumonia

First Phase III global study of Actemra/RoActemra in this setting to evaluate the safety and efficacy in collaboration with BARDA

03.19.20

Breaking News | Collaborations & Alliances

Altasciences, Amador Bioscience Enter Strategic Collaboration

The partnership aims to expand world-class capabilities and resources to promote drug development in China and North America.

03.18.20

Pfizer, BioNTech to Co-Develop Potential COVID-19 Vaccine

Will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection

03.18.20

Breaking News | Industry News

Weather to Play Major Role in Coronavirus Spread

Researchers predict potential spread and seasonality for COVID-19 based on climate where virus appears to thrive

03.16.20

Sanofi, Regeneron in COVID-19 Pact

Begin global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19

03.16.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BioNTech Reports Progress on COVID-19 Vaccine Program

Partnered with Fosun in China and Pfizer elsewhere; anticipates start of clinical testing for vaccine in late April 2020

03.16.20

Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development

Newsmakers: Thermo Fisher Scientific

Leon Wyszkowski discusses the company’s recent investments, the challenges biopharma companies face, and future needs in the outsourcing space

Online Exclusives03.16.20

Breaking News | Drug Development | Industry News

Gilead's Remdesivir Shows Promise in COVID-19

Antiviral drug being evaluated in two Phase III trials in patients with severe and moderate manifestations

03.13.20

Breaking News

Advaite Produces COVID-19 Rapid Response Diagnostic Kits

Diagnostic testing kit, ADVAITE RAPCOV, has ability to provide results in 15-30 minutes from a drop of fingertip blood and offers a solution for mass screening

Advaite 03.13.20

Breaking News